GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 311 | -774 | -4,940 | -1,922 | -1,269 |
| Depreciation Amortization | 450 | 212 | 467 | 201 | 102 |
| Income taxes - deferred | N/A | N/A | -12 | N/A | N/A |
| Accounts receivable | -394 | -88 | 133 | -29 | -65 |
| Accounts payable and accrued liabilities | 7 | 5 | 64 | 225 | 176 |
| Other Working Capital | 7 | 307 | 811 | 769 | 155 |
| Other Operating Activity | -299 | 324 | 2,806 | 250 | 155 |
| Operating Cash Flow | $82 | $-14 | $-671 | $-506 | $-746 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1 | -64 | -64 | -38 |
| Purchase Of Investment | N/A | N/A | -3,060 | -3,060 | -3,060 |
| Sale Of Investment | 3,060 | 3,060 | 3,060 | 3,060 | 3,060 |
| Purchase Sale Intangibles | -82 | N/A | -44 | -42 | -32 |
| Other Investing Activity | -82 | 0 | -44 | -42 | -32 |
| Investing Cash Flow | $2,978 | $3,059 | $-108 | $-106 | $-70 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -3,060 | N/A | 3,666 | 3,666 | 3,660 |
| Debt Repayment | N/A | N/A | 1,350 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 70 | 69 | 63 |
| Other Financing Activity | 0 | -3,060 | -3,713 | -3,060 | -3,060 |
| Financing Cash Flow | $-3,060 | $-3,060 | $1,373 | $675 | $663 |
| Beginning Cash Position | 1,208 | 1,208 | 614 | 614 | 614 |
| End Cash Position | 1,208 | 1,193 | 1,208 | 677 | 461 |
| Net Cash Flow | $N/A | $-15 | $594 | $63 | $-153 |
| Free Cash Flow | |||||
| Operating Cash Flow | 82 | -14 | -671 | -506 | -746 |
| Capital Expenditure | N/A | -1 | -64 | -64 | -38 |
| Free Cash Flow | 82 | -15 | -735 | -570 | -784 |